世界のマラリアワクチン市場2020:製造業者別、地域別、種類・用途別

【英語タイトル】Global Malaria Vaccines Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが出版した調査資料(GIR20MY09679)・商品コード:GIR20MY09679
・発行会社(調査会社):GlobalInfoResearch
・発行日:2020年5月(※2024年版があります。お問い合わせください)
・ページ数:100
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、マラリアワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。マラリアワクチンの種類別市場規模(赤血球前ワクチン、赤血球ワクチン、多抗原ワクチン)、用途別市場規模(病院、クリニック、公民館)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):GlaxoSmithKline plc、Sumaya Biotech、Sanaria Inc、Nobelpharma Co、GenVec
・地域別グローバル市場分析 2015年-2020年
・マラリアワクチンの北米市場(アメリカ、カナダ、メキシコ)
・マラリアワクチンのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・マラリアワクチンのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・マラリアワクチンの南米市場(ブラジル、アルゼンチン)
・マラリアワクチンの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:赤血球前ワクチン、赤血球ワクチン、多抗原ワクチン
・用途別分析:病院、クリニック、公民館
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論
【レポートの概要】

Market Overview
The global Malaria Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 14.4% in the forecast period of 2020 to 2025 and will expected to reach USD 23 million by 2025, from USD 14 million in 2019.

The Malaria Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Malaria Vaccines market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Malaria Vaccines market has been segmented into
Pre-Erythrocytic Vaccine
Erythrocytic Vaccine
Multi-antigen Vaccine

By Application, Malaria Vaccines has been segmented into:
Hospitals
Clinics
Community Centers

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Malaria Vaccines market presented in the report. This section sheds light on the sales growth of different regional and country-level Malaria Vaccines markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Malaria Vaccines market.

The report offers in-depth assessment of the growth and other aspects of the Malaria Vaccines market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Malaria Vaccines Market Share Analysis
Malaria Vaccines competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Malaria Vaccines sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Malaria Vaccines sales, revenue and market share for each player covered in this report.

The major players covered in Malaria Vaccines are:
GlaxoSmithKline plc
Sumaya Biotech
Sanaria Inc
Nobelpharma Co
GenVec

Among other players domestic and global, Malaria Vaccines market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Malaria Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Malaria Vaccines, with price, sales, revenue and global market share of Malaria Vaccines in 2018 and 2019.
Chapter 3, the Malaria Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Malaria Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Malaria Vaccines market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Malaria Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Malaria Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Malaria Vaccines Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Pre-Erythrocytic Vaccine
1.2.3 Erythrocytic Vaccine
1.2.4 Multi-antigen Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Malaria Vaccines Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Community Centers
1.4 Overview of Global Malaria Vaccines Market
1.4.1 Global Malaria Vaccines Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GlaxoSmithKline plc
2.1.1 GlaxoSmithKline plc Details
2.1.2 GlaxoSmithKline plc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GlaxoSmithKline plc SWOT Analysis
2.1.4 GlaxoSmithKline plc Product and Services
2.1.5 GlaxoSmithKline plc Malaria Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sumaya Biotech
2.2.1 Sumaya Biotech Details
2.2.2 Sumaya Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sumaya Biotech SWOT Analysis
2.2.4 Sumaya Biotech Product and Services
2.2.5 Sumaya Biotech Malaria Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanaria Inc
2.3.1 Sanaria Inc Details
2.3.2 Sanaria Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sanaria Inc SWOT Analysis
2.3.4 Sanaria Inc Product and Services
2.3.5 Sanaria Inc Malaria Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Nobelpharma Co
2.4.1 Nobelpharma Co Details
2.4.2 Nobelpharma Co Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Nobelpharma Co SWOT Analysis
2.4.4 Nobelpharma Co Product and Services
2.4.5 Nobelpharma Co Malaria Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 GenVec
2.5.1 GenVec Details
2.5.2 GenVec Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 GenVec SWOT Analysis
2.5.4 GenVec Product and Services
2.5.5 GenVec Malaria Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Malaria Vaccines Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Malaria Vaccines Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Malaria Vaccines Manufacturer Market Share in 2019
3.3.2 Top 6 Malaria Vaccines Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Malaria Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global Malaria Vaccines Sales and Market Share by Regions (2015-2020)
4.1.2 Global Malaria Vaccines Revenue and Market Share by Regions (2015-2020)
4.2 North America Malaria Vaccines Sales and Growth Rate (2015-2020)
4.3 Europe Malaria Vaccines Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Malaria Vaccines Sales and Growth Rate (2015-2020)
4.5 South America Malaria Vaccines Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Malaria Vaccines Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Malaria Vaccines Sales, Revenue and Market Share by Country
5.1.1 North America Malaria Vaccines Sales and Market Share by Country (2015-2020)
5.1.2 North America Malaria Vaccines Revenue and Market Share by Country (2015-2020)
5.2 United States Malaria Vaccines Sales and Growth Rate (2015-2020)
5.3 Canada Malaria Vaccines Sales and Growth Rate (2015-2020)
5.4 Mexico Malaria Vaccines Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Malaria Vaccines Sales, Revenue and Market Share by Country
6.1.1 Europe Malaria Vaccines Sales and Market Share by Country (2015-2020)
6.1.2 Europe Malaria Vaccines Revenue and Market Share by Country (2015-2020)
6.2 Germany Malaria Vaccines Sales and Growth Rate (2015-2020)
6.3 UK Malaria Vaccines Sales and Growth Rate (2015-2020)
6.4 France Malaria Vaccines Sales and Growth Rate (2015-2020)
6.5 Russia Malaria Vaccines Sales and Growth Rate (2015-2020)
6.6 Italy Malaria Vaccines Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Malaria Vaccines Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Malaria Vaccines Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Malaria Vaccines Revenue and Market Share by Regions (2015-2020)
7.2 China Malaria Vaccines Sales and Growth Rate (2015-2020)
7.3 Japan Malaria Vaccines Sales and Growth Rate (2015-2020)
7.4 Korea Malaria Vaccines Sales and Growth Rate (2015-2020)
7.5 India Malaria Vaccines Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Malaria Vaccines Sales and Growth Rate (2015-2020)
7.7 Australia Malaria Vaccines Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Malaria Vaccines Sales, Revenue and Market Share by Country
8.1.1 South America Malaria Vaccines Sales and Market Share by Country (2015-2020)
8.1.2 South America Malaria Vaccines Revenue and Market Share by Country (2015-2020)
8.2 Brazil Malaria Vaccines Sales and Growth Rate (2015-2020)
8.3 Argentina Malaria Vaccines Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Malaria Vaccines Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Malaria Vaccines Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Malaria Vaccines Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Malaria Vaccines Sales and Growth Rate (2015-2020)
9.3 Turkey Malaria Vaccines Sales and Growth Rate (2015-2020)
9.4 Egypt Malaria Vaccines Sales and Growth Rate (2015-2020)
9.5 South Africa Malaria Vaccines Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Malaria Vaccines Sales and Market Share by Type (2015-2020)
10.2 Global Malaria Vaccines Revenue and Market Share by Type (2015-2020)
10.3 Global Malaria Vaccines Price by Type (2015-2020)
11 Global Malaria Vaccines Market Segment by Application
11.1 Global Malaria Vaccines Sales Market Share by Application (2015-2020)
11.2 Global Malaria Vaccines Revenue Market Share by Application (2015-2020)
11.3 Global Malaria Vaccines Price by Application (2015-2020)
12 Market Forecast
12.1 Global Malaria Vaccines Sales, Revenue and Growth Rate (2021-2025)
12.2 Malaria Vaccines Market Forecast by Regions (2021-2025)
12.2.1 North America Malaria Vaccines Market Forecast (2021-2025)
12.2.2 Europe Malaria Vaccines Market Forecast (2021-2025)
12.2.3 Asia-Pacific Malaria Vaccines Market Forecast (2021-2025)
12.2.4 South America Malaria Vaccines Market Forecast (2021-2025)
12.2.5 Middle East & Africa Malaria Vaccines Market Forecast (2021-2025)
12.3 Malaria Vaccines Market Forecast by Type (2021-2025)
12.3.1 Global Malaria Vaccines Sales Forecast by Type (2021-2025)
12.3.2 Global Malaria Vaccines Market Share Forecast by Type (2021-2025)
12.4 Malaria Vaccines Market Forecast by Application (2021-2025)
12.4.1 Global Malaria Vaccines Sales Forecast by Application (2021-2025)
12.4.2 Global Malaria Vaccines Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Malaria Vaccines Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Malaria Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Malaria Vaccines Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 8. GlaxoSmithKline plc Malaria Vaccines Major Business
Table 9. GlaxoSmithKline plc Malaria Vaccines Total Revenue (USD Million) (2017-2018)
Table 10. GlaxoSmithKline plc SWOT Analysis
Table 11. GlaxoSmithKline plc Malaria Vaccines Product and Services
Table 12. GlaxoSmithKline plc Malaria Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Sumaya Biotech Basic Information, Manufacturing Base and Competitors
Table 14. Sumaya Biotech Malaria Vaccines Major Business
Table 15. Sumaya Biotech Malaria Vaccines Total Revenue (USD Million) (2017-2018)
Table 16. Sumaya Biotech SWOT Analysis
Table 17. Sumaya Biotech Malaria Vaccines Product and Services
Table 18. Sumaya Biotech Malaria Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Sanaria Inc Basic Information, Manufacturing Base and Competitors
Table 20. Sanaria Inc Malaria Vaccines Major Business
Table 21. Sanaria Inc Malaria Vaccines Total Revenue (USD Million) (2017-2018)
Table 22. Sanaria Inc SWOT Analysis
Table 23. Sanaria Inc Malaria Vaccines Product and Services
Table 24. Sanaria Inc Malaria Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Nobelpharma Co Basic Information, Manufacturing Base and Competitors
Table 26. Nobelpharma Co Malaria Vaccines Major Business
Table 27. Nobelpharma Co Malaria Vaccines Total Revenue (USD Million) (2017-2018)
Table 28. Nobelpharma Co SWOT Analysis
Table 29. Nobelpharma Co Malaria Vaccines Product and Services
Table 30. Nobelpharma Co Malaria Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. GenVec Basic Information, Manufacturing Base and Competitors
Table 32. GenVec Malaria Vaccines Major Business
Table 33. GenVec Malaria Vaccines Total Revenue (USD Million) (2017-2018)
Table 34. GenVec SWOT Analysis
Table 35. GenVec Malaria Vaccines Product and Services
Table 36. GenVec Malaria Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global Malaria Vaccines Sales by Manufacturer (2018-2019) (K Units)
Table 38. Global Malaria Vaccines Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global Malaria Vaccines Sales by Regions (2015-2020) (K Units)
Table 40. Global Malaria Vaccines Sales Market Share by Regions (2015-2020)
Table 41. Global Malaria Vaccines Revenue by Regions (2015-2020) (USD Million)
Table 42. North America Malaria Vaccines Sales by Countries (2015-2020) (K Units)
Table 43. North America Malaria Vaccines Sales Market Share by Countries (2015-2020)
Table 44. North America Malaria Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 45. North America Malaria Vaccines Revenue Market Share by Countries (2015-2020)
Table 46. Europe Malaria Vaccines Sales by Countries (2015-2020) (K Units)
Table 47. Europe Malaria Vaccines Sales Market Share by Countries (2015-2020)
Table 48. Europe Malaria Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific Malaria Vaccines Sales by Regions (2015-2020) (K Units)
Table 50. Asia-Pacific Malaria Vaccines Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific Malaria Vaccines Revenue by Regions (2015-2020) (USD Million)
Table 52. South America Malaria Vaccines Sales by Countries (2015-2020) (K Units)
Table 53. South America Malaria Vaccines Sales Market Share by Countries (2015-2020)
Table 54. South America Malaria Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 55. South America Malaria Vaccines Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Malaria Vaccines Sales by Countries (2015-2020) (K Units)
Table 57. Middle East & Africa Malaria Vaccines Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Malaria Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa Malaria Vaccines Revenue Market Share by Countries (2015-2020)
Table 60. Global Malaria Vaccines Sales by Type (2015-2020) (K Units)
Table 61. Global Malaria Vaccines Sales Share by Type (2015-2020)
Table 62. Global Malaria Vaccines Revenue by Type (2015-2020) (USD Million)
Table 63. Global Malaria Vaccines Revenue Share by Type (2015-2020)
Table 64. Global Malaria Vaccines Sales by Application (2015-2020) (K Units)
Table 65. Global Malaria Vaccines Sales Share by Application (2015-2020)
Table 66. Global Malaria Vaccines Sales Forecast by Regions (2021-2025) (K Units)
Table 67. Global Malaria Vaccines Market Share Forecast by Regions (2021-2025)
Table 68. Global Malaria Vaccines Sales Forecast by Type (2021-2025) (K Units)
Table 69. Global Malaria Vaccines Market Share Forecast by Type (2021-2025)
Table 70. Global Malaria Vaccines Sales Forecast by Application (2021-2025)
Table 71. Global Malaria Vaccines Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Malaria Vaccines Picture
Figure 2. Global Sales Market Share of Malaria Vaccines by Type in 2019
Figure 3. Pre-Erythrocytic Vaccine Picture
Figure 4. Erythrocytic Vaccine Picture
Figure 5. Multi-antigen Vaccine Picture
Figure 6. Malaria Vaccines Sales Market Share by Application in 2018
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Community Centers Picture
Figure 10. Global Malaria Vaccines Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Malaria Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Malaria Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Malaria Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Malaria Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Malaria Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Malaria Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Malaria Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Malaria Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Malaria Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Malaria Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Malaria Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Malaria Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Malaria Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Malaria Vaccines Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Malaria Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Malaria Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Malaria Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Malaria Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Malaria Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Malaria Vaccines Sales Market Share by Manufacturer in 2019
Figure 31. Global Malaria Vaccines Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Malaria Vaccines Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Malaria Vaccines Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Malaria Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 36. Global Malaria Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Malaria Vaccines Revenue Market Share by Regions (2015-2020)
Figure 38. Global Malaria Vaccines Revenue Market Share by Regions in 2018
Figure 39. North America Malaria Vaccines Sales and Growth Rate (2015-2020)
Figure 40. Europe Malaria Vaccines Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Malaria Vaccines Sales and Growth Rate (2015-2020)
Figure 42. South America Malaria Vaccines Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Malaria Vaccines Sales and Growth Rate (2015-2020)
Figure 44. North America Malaria Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Malaria Vaccines Sales Market Share by Countries (2015-2020)
Figure 46. North America Malaria Vaccines Sales Market Share by Countries in 2018
Figure 47. North America Malaria Vaccines Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Malaria Vaccines Revenue Market Share by Countries in 2018
Figure 49. United States Malaria Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Canada Malaria Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Mexico Malaria Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Europe Malaria Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Malaria Vaccines Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Malaria Vaccines Revenue Market Share by Countries in 2019
Figure 55. Germany Malaria Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 56. UK Malaria Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 57. France Malaria Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Russia Malaria Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Italy Malaria Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Asia-Pacific Malaria Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Malaria Vaccines Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Malaria Vaccines Revenue Market Share by Regions 2019
Figure 63. China Malaria Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Japan Malaria Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Korea Malaria Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 66. India Malaria Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Southeast Asia Malaria Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 68. South America Malaria Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Malaria Vaccines Sales Market Share by Countries in 2019
Figure 70. South America Malaria Vaccines Revenue Market Share by Countries in 2019
Figure 71. Brazil Malaria Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Malaria Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Middle East and Africa Malaria Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Malaria Vaccines Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Malaria Vaccines Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Malaria Vaccines Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Malaria Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Egypt Malaria Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Turkey Malaria Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 80. South Africa Malaria Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Global Malaria Vaccines Sales and Growth Rate (2021-2025) (K Units)
Figure 82. Global Malaria Vaccines Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Malaria Vaccines Market Forecast (2021-2025) (K Units)
Figure 84. Europe Sales Malaria Vaccines Market Forecast (2021-2025) (K Units)
Figure 85. Asia-Pacific Sales Malaria Vaccines Market Forecast (2021-2025) (K Units)
Figure 86. South America Sales Malaria Vaccines Market Forecast (2021-2025) (K Units)
Figure 87. Middle East & Africa Sales Malaria Vaccines Market Forecast (2021-2025) (K Units)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel


【掲載企業】

GlaxoSmithKline plc、Sumaya Biotech、Sanaria Inc、Nobelpharma Co、GenVec

★調査レポート[世界のマラリアワクチン市場2020:製造業者別、地域別、種類・用途別] (コード:GIR20MY09679)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のマラリアワクチン市場2020:製造業者別、地域別、種類・用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆